3 publicaciones etiquetados con "Digital Innovation"

The ceremony attended by European technology executives aims to promote digital innovation.​

The European Patient Digital Health Awards (PDHA) ceremony, orchestrated by MSD — known for their innovation in COVID-19 treatment —, recently honored Legit.Health for its groundbreaking work in healthcare technology. Marking a significant milestone, Legit.Health is celebrated as the first Spanish company to clinch the PDHA award, a testament to its commitment to transforming patient care through digital innovation.

Over 60 contenders from 18 European countries were in the running, but it was Legit.Health's novel approach in dermatology that stood out. Their application, capable of identifying over 232 dermatological conditions through a simple smartphone photograph, impressed the jury, which included patient representatives and entrepreneurial experts. The honor specifically recognized their advancement in "New ways to interact with healthcare teams and providers".

The European initiative reinforced the vital role of innovation in healthcare and the evolution of technology, both for patients and for healthcare providers and professionals.

Alfonso Medela, a key figure at Legit.Health, brings personal experience to the table, having managed chronic urticaria since his youth. At only 26, he spearheaded the development of this tech solution, aiming to improve the lives of millions facing similar challenges.

Legit.Health 's platform, employing artificial intelligence (AI) and advanced computer vision algorithms, is more than just a diagnostic tool. It empowers patients by enabling them to autonomously monitor their skin conditions, fostering better communication with healthcare professionals.

AI streamlines routine tasks, allowing doctors to concentrate on the most crucial aspect of healthcare - the patients.

These prestigious awards, initiated by influential entities like MSD, are essential in spotlighting the pivotal role of digital innovation in healthcare. They recognize technologies like Legit.Health that aid physicians in making informed decisions, improving patient-doctor communication, and enhancing diagnostic accuracy.

A tool that uses artificial intelligence (AI) and computer vision algorithms to help doctors reach where they cannot. Although, Alfonso Medela, promoter of Legit.Health, explains: "our diagnostic algorithms never replace the doctor, but provide him with valuable information to make a decision". Medela has suffered from chronic urticaria since he was young and, at only 26 years old, he created this technology to alleviate the problems of millions of people in his situation.

This platform is presented as a device for doctors and patients based on Deep Learning and computer vision algorithms, which allow the detection and monitoring of skin conditions. Helping doctors in their diagnosis, and patients empowering them so they can be autonomous in the monitoring of their skin pathology, improving like this communication with the professional.

Technology was born to stay and help physicians perform all those routine and administrative tasks that impeded them from providing personalized patient care. Andy Aguilar, CEO of Legit.Health and patient with several chronic skin diseases, says: "Artificial intelligence helps to perform all those tasks that can be automated so that the doctor can focus on what is most important: the patient".

Awards like this, organised by important establishments like the pharmaceutical company MSD, are necessary to highlight the importance of innovation in the health sector and recognize applications that are positioned as a support in the final decisions of many doctors. In the communication, they have with their patients, as well as in the final diagnosis.

About Legit.Health​

Legit.Health is the revolutionary dermatological application based on artificial intelligence and Deep Learning technology, designed for Next-generation dermatologists. Health professionals who take advantage of the opportunities offered by new technologies to improve the state of the art in their field.

The algorithms were designed by Legit.Health is capable of, through simple photography, automatically fill in most of the medical grading systems, such as PASI, SCORAD, UAS, GAGS, and many more dermatology scoring systems. Becoming the tool that makes life easier for many doctors and patients. ​​In addition, the data is highly protected and stored in an encrypted system.

Legit.Health helps Next-generation dermatologists to offer a diagnosis much faster than the one achieved traditionally, reducing the workload of the doctor allowing them to estimate the severity of the pathology in a faster way and supporting their knowledge by offering an objective diagnosis.

In short, a tool that combines objectivity and precision in the report of a pathology and that allows doctors to maintain daily and effective communication with their patients. As well as being constantly informed of the changes in the pathology of the patient.

About the pharmaceutical company MSD​

The pharmaceutical company MSD is one of the largest in the healthcare ecosystem and they have a clear objective: to save and improve lives.

They aim to make a difference in the lives of people around the world through innovative medicines, vaccines and animal health products. They are committed to being the first biopharmaceutical group dedicated to intensive research and to providing innovations and solutions for the present and the future.

Get access now​

This free 23-day trial of Legit.Health gives clinics and hospitals a hands-on look at how to drive increased adherence and improve patient outcomes, as well as improving efficiency and overall quality of life.

The Transformative Impact of Our AI-Driven Dermatological Technology on Society and Healthcare​

Since she was little, Andy Aguilar knew that many things were wrong with her skin. And when she needed doctors, she was met with an ordeal.

She was held back by primary care, and then passed around from specialist to specialist, collecting incorrect diagnosis after incorrect diagnosis and taking the brunt of the consequences of the misguided treatments that came with them as her frustration with her healthcare providers grew. Each new appointment came with its ever-extending waiting period, as her symptoms worsened before her eyes.

That's why she founded Legit.Health, based on her experience as a patient, and with first-hand knowledge of how to fix the system and rescue patients.

Addressing Critical Issues in Access, Timeliness, and Comprehensive Care​

By providing an efficient and highly accurate tool, our technology not only improves patient outcomes but significantly enhances the sustainability and equity of health systems globally. Indeed, our AI technology is not just about offering advanced diagnosis and monitoring capabilities. It's about transforming the patient experience by improving quality of life, enhancing health outcomes, empowering patients, and improving the overall efficiency of dermatological services. It's a comprehensive solution designed with a clear focus on patient-centric care.

Through the continuous tracking and analysis of these KPIs and metrics, we can assess the effectiveness of our AI technology in addressing critical healthcare issues and adjust our strategies as necessary for further improvements.

Reducing Waiting Time for Consultations​

Traditionally, patients face considerable waiting times for dermatological consultations, with the timeframe often extending to several weeks or even months. Our AI technology is designed to mitigate this issue. The ability to accurately analyze skin images, it allows for prompt diagnosis and accelerates the medical decision-making process. As a result, patients can begin their treatment much earlier, dramatically reducing the waiting time and overall stress associated with these delays.

Metrics​

• Average wait time from appointment booking to consultation
• Average wait time from consultation to diagnosis.

Democratizing Care Access in Rural Areas and Among At-risk Collectives​

Access to dermatological care is often a significant challenge for patients living in rural areas and for at-risk collectives. However, our AI technology bridges this divide by offering a platform for remote diagnosis and monitoring. Patients can capture and upload images of their skin conditions from their homes, enabling them to access dermatological care without the need to travel to healthcare facilities. This inclusivity extends the reach of health systems, ensuring that everyone, irrespective of their location or societal status, can receive the care they need.

Metrics​

• Number of rural and at-risk patients using the AI tool
• Percentage increase in the utilization of dermatological services in rural areas/at-risk collectives.

Preventing Neglected Conditions from Triggering Other Diseases​

Neglected skin conditions can often lead to other health issues, turning a seemingly simple dermatological problem into a complex medical challenge. Our AI technology encourages proactive healthcare by facilitating the early detection of skin conditions, reducing the chances of neglect. The tool provides an avenue for continuous monitoring of chronic skin diseases like psoriasis and dermatitis. This way, patients and doctors can monitor disease progression and adjust treatment strategies as needed, preventing any unnecessary complications.

Metrics​

• Reduction in the number of secondary complications arising from neglected skin conditions,
• Reduction in the progression of chronic skin conditions.

Early Detection of Skin Cancer for Improved Survival Rates​

Timely diagnosis of skin cancer significantly increases survival rates. Research shows that for each month of delay in diagnosis, there is a 15% decrease in survival rates. Our AI tool employs advanced image recognition capabilities to detect early signs of malignant skin diseases, drastically cutting down diagnosis time. This prompt action allows for earlier intervention and treatment, thereby increasing the chances of survival and reducing patient mortality rates.

Metrics​

• Increase in early-stage skin cancer detection rates
• Increase in skin cancer survival rates.

Filling the Gap in Medical Care in Rural Areas​

Rural areas often face a shortage of dermatological specialists, leading to reduced access to necessary care. Our AI technology effectively addresses this challenge by bringing expert dermatological diagnosis and monitoring to patients' homes, irrespective of location. With its intuitive interface and robust diagnostic capabilities, our tool empowers patients to play an active role in their healthcare journey, thus expanding the reach of quality medical care in rural areas.

Metrics​

• Number of rural users of the AI tool
• Reduction in the number of untreated or late-treated skin cases in rural areas.

Improving Quality of Life​

Skin conditions, particularly chronic ones, can profoundly impact an individual's quality of life. Our AI technology is built to alleviate this burden. With the ability to monitor conditions like psoriasis and dermatitis from home, patients can avoid the stress and discomfort associated with regular hospital visits. Moreover, rapid diagnosis enables quicker treatment, providing relief from symptoms and improving overall well-being. Our technology's remote access capability also saves patients' time and travel expenses, thereby improving their day-to-day living conditions.

Metrics​

• Patient-reported outcome measures (PROMs) for skin disease-related quality of life (like the Dermatology Life Quality Index, DLQI).

Achieving Better Health Outcomes​

The primary goal of any healthcare technology is to improve health outcomes, and our AI tool excels in this regard. By offering an avenue for early detection of malignant skin diseases, it facilitates prompt intervention, increasing the chances of successful treatment. In chronic conditions, the AI aids in consistent monitoring and helps physicians make informed decisions on treatment adjustments, resulting in more effective disease management. This proactive and personalized approach leads to significantly better health outcomes and reduced complication rates.

Metrics​

• Reduction in complication rates
• Improved disease management as measured by the reduction in symptom severity or disease progression
• Patient recovery rates.

Increasing Autonomy and Control of Patients​

Our AI technology empowers patients to play an active role in their healthcare journey. By providing them with the tools to capture and upload images of their skin conditions, patients become integral participants in their own diagnosis process. They can monitor their condition in real time, which gives them a sense of control and autonomy over their health. The tool's user-friendly interface and the ability to provide immediate feedback foster a sense of ownership and enhance patient engagement in their care.

Metrics​

• Patient engagement metrics such as the frequency of use of the AI tool
• Patient satisfaction rates
• Patient-reported measure of perceived control over their health

Reducing the Waiting Lists​

Waiting lists for dermatological consultations can often be lengthy, posing significant delays to treatment. Our AI technology dramatically reduces these waiting times by providing immediate and accurate diagnoses based on image recognition. By bypassing the need for in-person consultation for diagnosis, it allows for a faster turnaround from symptom onset to treatment initiation. This efficiency not only reduces waiting lists but also frees up dermatologists to handle more complex cases, leading to an overall more efficient healthcare system.

Metrics​

• Reduction in the number of patients on waiting lists for dermatological consultations
• Reduction in the average time patients spend on waiting lists.

Conclusion​

Andy founded Legit.Health, based on her experience as a patient, with the idea that the use of her application would allow patients to have greater autonomy to report images with relevant clinical data for their doctors, as well as resources that will empower them by providing them with information and training on their pathology and its management, and the generation of a community in which they will feel accompanied and supported, impacting their quality of life.

Furthermore, the use of the Legit.Health application, an artificial intelligence tool with image recognition, will allow early diagnosis of malignant diseases and will facilitate the monitoring of the evolution of chronic skin diseases, speeding up clinical decision-making at every opportune moment. to offer the best assistance to their patients, improving the efficiency of the health system.

This collaboration will integrate Legit.Health's innovative technology into Aptar Digital Health's proprietary digital health platform to better manage and treat skin conditions

Aptar Digital Health, a global expert in Software as a Medical Device (SaMD), digital Patient Support Programs (PSPs) and disease management solutions, today announced a new partnership with Legit.Health, an innovative artificial intelligence (AI)-based medical device (CE-marked) software company, which aims to transform patient care and increase patient adherence to better manage skin conditions.

Legit.Health's state-of-the-art technology, which supports the diagnosis of approximately 300 conditions, including atopic dermatitis, psoriasis and skin cancer, will be integrated into Aptar's Digital Health proprietary platform. Focused on enhancing patient care and increasing patient autonomy, this advanced digital solution will support healthcare professionals (HCPs) to diagnose skin conditions earlier and will enable patients to start sooner on treatment plans to improve their overall quality of life. The solution may also be used to facilitate patient enrolment in clinical trials.

Legit.Health's use of AI for monitoring disease progression through automated, clinically validated scoring systems such as the Psoriasis Area Severity Index (PASI) and SCORing Atopic Dermatitis (SCORAD) will be leveraged within this partnership. This will help to ensure patients receive the most accurate and timely information to manage and treat their skin condition more effectively. The AI-powered technology also extends to the quantification of the intensity, count and extent of the visible clinical signs of skin conditions, offering HCPs a more precise measure of disease severity, an indicator considered critical in determining the most appropriate treatment.

This strategic partnership is set to drive digital transformation in the healthcare sector. The combined expertise of Aptar Digital Health and Legit.Health will pave the way towards harnessing the power of AI to improve patient experiences and outcomes in immuno-dermatology.

Since 2021, Aptar Digital Health has been growing our portfolio of technology partners to provide improved solutions for patients in multiple therapeutic areas such as cardiology, neurology and visual acuity. With this new partnership, Aptar Digital Health is acquiring the ability to leverage AI technology to accelerate the diagnosis and monitoring of skin conditions.

One of our main aims within the medical assistance process in the field of dermatology is to be able to offer patients the opportunity of having the earliest and most accurate diagnosis, with the appropriate referral and treatment to reduce uncertainty and waiting times. Legit.Health's technology helps the medical practitioner to provide this kind of care to their patients and today, thanks to our partnership with Aptar Digital Health, we will be able to reach even more people who will benefit from our service.

About Legit.Health​

Legit.Health is the revolutionary dermatological application based on artificial intelligence and Deep Learning technology,designed for Next-generation dermatologists. Health professionals who take advantage of the opportunities offered by new technologies to improve the state of the art in their field.

The algorithms were designed by Legit.Health is capable of, through simple photography, automatically fill-in most of the medical grading systems, such asPASI,SCORAD,UAS,GAGS, and many more dermatology scoring systems. Becoming the tool that makes life easier for many doctors and patients. In addition, the data is highly protected and stored in an encrypted system.

Legit.Health helps Next-generation dermatologists to offer a diagnosis much faster than the one achieved traditionally, reducing the workload of the doctor allowing them to estimate the severity of the condition in a faster way and supporting their knowledge by offering an objective diagnosis.

In short, a tool that combines objectivity and precision in the report of a condition and that allows doctors to maintain daily and effective communication with their patients. As well as being constantly informed of the changes in the condition of the patient.

About Aptar Digital Health​

Aptar Pharma's Digital Health division is part of AptarGroup, Inc., a global leader in drug and consumer product dosing, dispensing and protection technologies. Aptar Digital Health creates end-to-end solutions to enhance patient experiences every day, leveraging a holistic ecosystem of digital interventions. Amplified by an industry-leading portfolio of products and solutions, Aptar Digital Health's offering combines mobile and web apps, connected drug delivery systems, onboarding, training and advanced data analytics services to actively empower patients and create a positive treatment journey. Aptar is headquartered in Crystal Lake, Illinois and has 13,500 dedicated employees in 20 countries. For more information, please visit www.aptardigitalhealth.com and www.aptar.com.

Get access now​

This free 23-day trial of Legit.Health gives clinics and hospitals a hands-on look at how to drive increased adherence and improve patient outcomes, as well as improving efficiency and overall quality of life.